These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6811910)

  • 21. Buprenorphine self-administration by rhesus monkey.
    Mello NK; Bree MP; Mendelson JH
    Pharmacol Biochem Behav; 1981 Aug; 15(2):215-25. PubMed ID: 7198266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of secondary buprenorphine (Temgesic) dependence].
    Benos J
    Nervenarzt; 1983 May; 54(5):259-61. PubMed ID: 6866170
    [No Abstract]   [Full Text] [Related]  

  • 23. Establishment of orally delivered drugs as reinforcers for rhesus monkeys: some relations to human drug dependence.
    Meisch RA; Carroll ME
    NIDA Res Monogr; 1981 Jul; 37():197-209. PubMed ID: 6119617
    [No Abstract]   [Full Text] [Related]  

  • 24. Dependence potential of drotebanol, codeine and thebaine tested in rhesus monkeys.
    Yanagita T; Miyasato K; Oinuma N; Yiyohara H
    Bull Narc; 1977; 29(1):33-46. PubMed ID: 405065
    [No Abstract]   [Full Text] [Related]  

  • 25. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
    Negus SS
    J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of centrally acting peptides on the chronic actions of buprenorphine in the rat.
    Bhargava HN
    NIDA Res Monogr; 1982 Apr; 41():134-40. PubMed ID: 6126811
    [No Abstract]   [Full Text] [Related]  

  • 27. Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure.
    Walker EA; Zernig G; Woods JH
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1345-52. PubMed ID: 7791107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of tolerance and dependence with the delta-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation.
    Brandt MR; Furness MS; Rice KC; Fischer BD; Negus SS
    J Pharmacol Exp Ther; 2001 Nov; 299(2):629-37. PubMed ID: 11602675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous phencyclidine self-administration by rhesus monkeys leading to physical dependence.
    Balster RL; Woolverton WL
    NIDA Res Monogr; 1979; 27():205-11. PubMed ID: 121336
    [No Abstract]   [Full Text] [Related]  

  • 30. [Behavioral changes in rhesus monkeys induced by repeated administration of ephedrine].
    Kato S
    Seishin Shinkeigaku Zasshi; 1985; 87(8):583-94. PubMed ID: 4089042
    [No Abstract]   [Full Text] [Related]  

  • 31. Behavioral effects of buprenorphine and diprenorphine under a multiple schedule of food presentation in squirrel monkeys.
    Dykstra LA
    J Pharmacol Exp Ther; 1983 Aug; 226(2):317-23. PubMed ID: 6875844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone.
    Sell SL; McMahon LR; France CP
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1167-73. PubMed ID: 12766254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of naloxone and buprenorphine on intravenous acetaldehyde self-injection in rats.
    Myers WD; Ng KT; Singer G
    Physiol Behav; 1984 Sep; 33(3):449-55. PubMed ID: 6514833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dependence potential of zopiclone studied in monkeys.
    Yanagita T
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():216-27. PubMed ID: 6892368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buprenorphine effects on plasma luteinizing hormone and prolactin in male heroin addicts.
    Mendelson JH; Ellingboe J; Mello NK; Kuehnle J
    J Pharmacol Exp Ther; 1982 Feb; 220(2):252-5. PubMed ID: 7057390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential tolerance development to buprenorphine-, diprenorphine-, and heroin-induced disruption of food-maintained responding in macaque monkeys.
    Lukas SE; Mello NK; Bree MP; Mendelson JH
    Pharmacol Biochem Behav; 1988 Aug; 30(4):977-82. PubMed ID: 3227044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unlimited access intravenous drug self-administration in rhesus monkeys.
    Balster RL; Woolverton WL
    Fed Proc; 1982 Feb; 41(2):211-5. PubMed ID: 7199481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of naltrexone on cocaine self-administration by rhesus monkey.
    Mello NK; Kamien JB; Mendelson JH; Lukas SE
    NIDA Res Monogr; 1990; 105():617-8. PubMed ID: 1876146
    [No Abstract]   [Full Text] [Related]  

  • 39. Preclinical evaluation of the effects of buprenorphine, naltrexone and desipramine on cocaine self-administration.
    Mello NK
    NIDA Res Monogr; 1990; 105():189-95. PubMed ID: 1875998
    [No Abstract]   [Full Text] [Related]  

  • 40. Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys.
    Brandt MR; Cabansag SR; France CP
    J Pharmacol Exp Ther; 1997 Aug; 282(2):574-84. PubMed ID: 9262317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.